Moreover, radiotherapy promotes CD8+-T-lymphocyte mediated tumour cell killing via ICAM-1 and MIC A/B so that inflammatory remodelling of the microenvironment leads to increased tumour cell death (reviewed by Donlon [34]). Here, CD8A is linked to neoplasm.